Diocolano, Al-maarij .

HRN: 28-69-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
OXACILLIN 500MG (VIAL)
03/14/2026
03/20/2026
IV
375mg
Q6
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: